RENBP and neoplasm: Several mechanisms have been reported to explain Ag-negative relapses, including selection of pre-existing Ag-negative tumor cells, mutation or splicing-variation, altered maturation/trafficking affecting target-Ag expression, epitope masking, and lineage switch/transdifferentiation (Fig. 1).